Rapid Evaluation of Amantadine for Treatment of Cocaine Abuse/Dependence - 4
NCT ID: NCT00000301
Last Updated: 2016-07-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
INTERVENTIONAL
1996-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effectiveness of Amantadine and Propranolol for Treating Cocaine Dependence - 2
NCT00158132
Rapid Evaluation of Baclofen for Treatment of Cocaine Abuse/Dependence - 6
NCT00000303
Effectiveness of Memantine in Treating Cocaine-Dependent Individuals - 2
NCT00134901
Cocaine Effects in Humans: Physiology and Behavior - 1
NCT00000200
Development of Human Laboratory Study Model of Cocaine Relapse Prevention. - 1
NCT00040066
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
TREATMENT
DOUBLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Amantadine
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute on Drug Abuse (NIDA)
NIH
University of California, Los Angeles
OTHER
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Walter Ling, M.D.
Role: PRINCIPAL_INVESTIGATOR
Friends Research Institute, Inc.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Friends Research Institute
Los Angeles, California, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Shoptaw S, Kintaudi PC, Charuvastra C, Ling W. A screening trial of amantadine as a medication for cocaine dependence. Drug Alcohol Depend. 2002 May 1;66(3):217-24. doi: 10.1016/s0376-8716(01)00205-8.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
P50-09260-4
Identifier Type: -
Identifier Source: secondary_id
NIDA-09260-4
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.